Powered by: Motilal Oswal
2025-12-23 05:01:53 pm | Source: Emkay Global Financial Services Ltd
Buy Waaree EnergiesLtd for the Target Rs. 4,260 By Emkay Global Financial Services Ltd
Buy Waaree EnergiesLtd for the Target Rs. 4,260 By Emkay Global Financial Services Ltd

We initiate coverage on Waaree Energies with BUY and Mar-27E TP of Rs4,260 (48% upside), valuing the core PV business at 14x Mar-28E EV/EBITDA. India’s solar manufacturing development has been supported by favorable regulations like ALMM, BCD, and DCR and, despite the module overcapacity now, integration of cell and wafer-ingots as well as the upcoming ALMMs on them should support first movers like Waaree, driving their competitiveness. The profit pool will shift from module to cell and to wafer-ingot, but book margins and returns are likely to stay protected. FY25-28E revenue/EBITDA/APAT CAGR is 36%/48%/40%, on the back of major integrated expansions in FY26-27 leading to 33% module volume CAGR and a largely stable EBITDAM at 23-24%. Waaree is further diversifying into BESS, transformers, inverters, and electrolyzers, besides its already established EPC and O&M presence – this allows it a higher wallet share with customers. We build in BESS capex for 3.5GWh albeit no earnings in FY28E, valuing it at 1x EV/invested capital of Rs20.7bn.

ALMMs to protect integrated players; Waaree’s order book secured for 2-3 years Installed solar power capacity CAGR in India is expected at ~30GWac on average in FY26- 28E, given GoI target of ~300GWac by CY30 (200GW by end-FY28E vs 106GW at endFY25). This implies module-cell demand of >45GWdc pa on average, at 1.4x loading. India’s module capacity surpassed 70GW in FY25; it is expected to reach ~200GW by FY28. However, with ALMM II (cell) and the consequent DCR requirement, installed cell capacity would be crucial; per our industry checks, cell capacity would be at 40/60/80GW as of end-FY26/27/28. Annual capacity utilization of 85% implies ~50GW of domestic cell production, albeit difficult to achieve at the industry level. Waaree’s core order-book, estimated at ~Rs440bn (at end-Q2FY26), provides secured revenue till mid-FY28E, even after building in the rapid growth. Beyond FY28, the proposed ALMM-III (wafer-ingot) should set in, with FY30 capacity likely at ~60GW, thus protecting integrated player

Integration to support business margins; major capacity expansion underway Waaree is expanding its module capacity from 18.7GWpa as of end-Q2 to 26.7GW by end-FY26, cell capacity from 5.4GW to 15.4GW by end-FY27, and setting up new waferingot capacity of 10GW by end-FY27, at total capex of Rs118bn. 6GW of integrated capacity is under the PLI scheme. While module-cell integration is likely to expand margin by ~3% (all things remaining the same), wafer-ingot could add another 1-2% (in our view), not adjusting the capacity utilization difference, which provides further upside. Cell ALMM wef Jun-26 would also increase DCR share, wherein margin is 5-6% higher than Waaree’s blended rate. The mgmt has given guidance for 22-24% sustainable EBITDAM, which we believe is reasonable even after keeping some cushion from the rising domestic capacities and the near-term US-based uncertainties.

We initiate coverage on Waaree with BUY and TP of Rs4,260 Our TP estimate is basis SOTP valuation, with core target EV/EBITDA of 14x FY28E and BESS at 1.0x EV/invested capital. Key risks: competitive, technology, policy, commodity.

 

For More  Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH000000354

 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here